Evidence map›Paper›PMID 38360625›Full record

ArticleMalaria journal2024

Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia.

Mathilde Grimée, Costanza Tacoli, Mirco Sandfort, Thomas Obadia, Aimee R Taylor, Amélie Vantaux, Leanne J Robinson, Dysoley Lek, Rhea J Longley, Ivo Mueller and 3 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 6 citations in OpenAlex.

  1. Validation of serological markers of recent exposure toThe Lancet regional health. Western Pacific · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Heterogeneous mosquito exposure increasesProceedings. Biological sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Mathilde GriméeInfectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France. mathilde.grimee@pasteur.fr.
Costanza TacoliMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Mirco SandfortCollège Doctoral, Sorbonne Université, Paris, France.
Thomas ObadiaInfectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France.
Aimee R TaylorInfectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France.
Amélie VantauxMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Leanne J RobinsonBurnet Institute, Melbourne, Australia.
Dysoley LekNational Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Rhea J LongleyPopulation Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Ivo MuellerMalaria Parasites and Hosts, Institut Pasteur, Université Paris Cité, Paris, France.
Jean PopoviciMalaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Michael T White *Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France. michael.white@pasteur.fr.
Benoît Witkowski *Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. bwitkowski@pasteur.mg.
Institut Pasteur du Cambodge · KHUniversité Paris Cité · FRCambodia National Malaria Center · KHInstitut Pasteur · FRPapua New Guinea Institute of Medical Research · PGThe University of Melbourne · AUUniversité Sorbonne Nouvelle · FR

Funding

Understanding, tracking and eliminating malaria transmission in the Asia - Pacific RegionU19AI129392 · NIAID · WALTER AND ELIZA HALL INST MEDICAL RES · PI Ivo J Mueller, Leanne Robinson · 2017 to 2026
$7.1M
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malariaR01AI175134 · NIAID · INSTITUT PASTEUR DU CAMBODGE · PI TINEKE CANTAERT, Jean POPOVICI · 2023 to 2026
$2.3M
NIAID NIH HHS R01 AI175134NIAID NIH HHS U19 AI129392NIH HHS R01AI175134
6 · The paper itself

Abstract

backgroundOver the last decades, the number of malaria cases has drastically reduced in Cambodia. As the overall prevalence of malaria in Cambodia declines, residual malaria transmission becomes increasingly fragmented over smaller remote regions. The aim of this study was to get an insight into the burden and epidemiological parameters of Plasmodium infections on the forest-fringe of Cambodia.

methods950 participants were recruited in the province of Mondulkiri in Cambodia and followed up from 2018 to 2020. Whole-blood samples were processed for Plasmodium spp. identification by PCR as well as for a serological immunoassay. A risk factor analysis was conducted for Plasmodium vivax PCR-detected infections throughout the study, and for P. vivax seropositivity at baseline. To evaluate the predictive effect of seropositivity at baseline on subsequent PCR-positivity, an analysis of P. vivax infection-free survival time stratified by serological status at baseline was performed.

resultsLiving inside the forest significantly increased the odds of P. vivax PCR-positivity by a factor of 18.3 (95% C.I. 7.7-43.5). Being a male adult was also a significant predictor of PCR-positivity. Similar risk profiles were identified for P. vivax seropositivity. The survival analysis showed that serological status at baseline significantly correlated with subsequent infection. Serology is most informative outside of the forest, where 94.0% (95% C.I. 90.7-97.4%) of seronegative individuals survived infection-free, compared to 32.4% (95% C.I.: 22.6-46.6%) of seropositive individuals.

conclusionThis study justifies the need for serological diagnostic assays to target interventions in this region, particularly in demographic groups where a lot of risk heterogeneity persists, such as outside of the forest.

Indexed as

MalariaMalaria, FalciparumMalaria, VivaxAdultCambodiaCross-Sectional StudiesForestsHumansIncidenceMalePlasmodium falciparumPlasmodium vivaxCambodiaForestGreater Mekong SubregionPlasmodium vivaxRisk stratificationSerology

Identifiers

PMID38360625
PMCPMC10870639
OpenAlexW4391845052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.